NCT03403777 2019-03-05Avelumab in Refractory Testicular Germ Cell Cancer.National Cancer Institute, SlovakiaPhase 2 Completed8 enrolled
NCT01466231 2016-01-12Everolimus in Refractory Testicular Germ Cell CancerNational Cancer Institute, SlovakiaPhase 2 Completed15 enrolled